Detailed Narrative
Record Financial Performance in FY25
Vishnu Chemicals reported its highest-ever operating revenue of INR1,446 crores in FY25, marking a 19% year-on-year increase from INR1,212.6 crores in FY24. Consolidated PAT for FY25 grew 25% to INR126.6 crores, up from INR101.1 crores in FY24, with an EBITDA margin of 15.8% and a PAT margin of 8.8%. The company also achieved a robust 19% Return on Capital Employed (ROCE) for the year.
Strong Q4 FY25 Results Driven by Barium Segment
For Q4 FY25, consolidated operating revenues increased 31% year-on-year to INR392.6 crores. PAT saw a significant 40% year-on-year increase to INR38.9 crores, marking the highest ever for the company. While Q4 EBITDA grew only 1% year-on-year to INR64.1 crores, resulting in a 16.3% margin, the Barium segment notably outperformed, with volumes growing by approximately 30% in FY25, compared to 9% in Chromium.
Strategic Backward Integration and Deleveraged Balance Sheet
The company's investment in Ramadas Minerals, acquired in Q2 FY24, has already recouped 60% of its investment in just six quarters, significantly contributing to Barium's EBITDA margin growth. Vishnu Chemicals maintained a strong financial position with a consolidated debt-to-equity ratio of 0.37x, a reduction for the seventh consecutive year. Cash and cash equivalents stood at INR80 crores, and the current ratio was healthy at 1.7x.
Outlook on Strontium Carbonate and Chrome Mine Projects
Vishnu Chemicals is focused on commissioning its Strontium Carbonate project, with commercial production expected by mid-June and sales activity commencing in H2 FY25. This new vertical is projected to generate INR250-300 crores in revenue over the next two years. Additionally, the company anticipates starting production from its acquired chrome mine in South Africa by September/October, aiming for 70-80% captive sourcing in Year 1 and up to 90% in Year 2, which is expected to significantly improve EBITDA and secure raw material supply for 25-30 years.
FY26 Growth and Margin Guidance
Management anticipates a 15-20% top-line growth for FY26, which is expected to translate into improved EBITDA. They project consolidated EBITDA margins to exceed 20% within two years, driven by the positive performance in Barium and the full impact of Chromium's backward integration. Standalone gross margins are expected to rebound to the 44-45% range in the coming quarters, supported by value addition and export market stabilization.
Capacity Utilization and Expansion Plans
In FY25, Barium capacity utilization was in the mid-60s, increasing to 77% in Q4, with a target to reach 80% this year. Chromium Chemicals utilization is in the mid-80s, with an optimal range for both segments targeted at 80-90%. The company is optimistic about increasing capacities in the Barium vertical, including Precipitated Barium Sulphate and Barium Carbonate, with a brownfield expansion timeline of approximately 9 months from groundbreaking.
Export Market Dynamics and Pricing Strategy
Export sales grew 16% year-on-year in FY25, contributing 46% to the total sales mix. While Chromium pricing remained stable to slightly soft in recent months due to geopolitical uncertainties and cautious buying, demand fundamentals are intact, with recovery expected in H1 FY26, particularly from North America, Europe, and Southeast Asia. The company implemented price increases in Chromium (Q3 FY25) and Barium (~20% throughout FY25) but controlled consolidated price hikes due to export market softness and Red Sea crisis impact on freight, prioritizing volume growth.